• Newtrend Group Holding named Zhang Qian as independent non-executive director effective May 14, 2026, replacing Li Ling, who stepped down from board role.
• Zhang is deputy general manager at Bio-Engine Biotechnology (Beijing), overseeing marketing, quality management, product, solutions center; previously served as R&D director at Shenzhen Kexing Tianhe Biotech, held a director role at Sinovac Biopharmaceutical, worked as food scientist at Lawrence Foods.
• Audit committee membership shifted to Song Jingjin, Lu Jiongyu, Zhang Qian; nomination committee now includes Wang Xiaoqiang, Song Jingjin, Zhang Qian.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Newtrend Group Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260514-12159707), on May 14, 2026, and is solely responsible for the information contained therein.